Taxus Cardium Pharmaceuticals Group Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. | Key People and Executives

Christopher J. Reinhard

Chairman, President, CEO, CFO, Treasurer & CAO

Jia Yue Zhang

Executive Chairman

Wei-Wei Zhang

Director

Andrew M. Leitch

Independent Director

John F. Wallace

Independent Director

Edward W. Gabrielson

Independent Director

Murray H. Hutchison

Independent Director

Gerald J. Lewis

Independent Director

Christopher J. Reinhard

Chairman, President, CEO, CFO, Treasurer & CAO

Gabor M. Rubanyi

Chief Scientific Officer

Lois A. Chandler

Vice President-Biologics Development

Jia Yue Zhang

Executive Chairman

Wei-Wei Zhang

Director

Duane M. Linstrom

Secretary

Andrew M. Leitch

Independent Director

John F. Wallace

Independent Director

Edward W. Gabrielson

Independent Director

Murray H. Hutchison

Independent Director

Gerald J. Lewis

Independent Director

View Profile

Address	11750 Sorrento Valley Road San Diego California 92121 United States
Employees	-
Website	http://www.cardiumthx.com
Updated	07/08/2019
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company . The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease; and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers.